人神经类器官模型再现弥漫性中线胶质瘤患者肿瘤复杂性
该研究利用3株DMG患者来源异种移植细胞系,与人iPSC来源的平面神经类器官共培养,并用空间转录组学分析。结果显示肿瘤细胞整合入类器官并与小胶质细胞和星形胶质细胞相互作用,其转录组和蛋白组与患者活检高度一致,并可用于药物旁观者毒性筛选。
要点
- 人平面神经类器官可支持DMG细胞整合与生长,再现肿瘤微环境交互。
- 类器官中DMG细胞的转录组和蛋白组与患者活检高度相关。
- 该模型可用于传统单培养无法实现的药物旁观者毒性筛选。
核心结论
- 人平面神经类器官为DMG提供了可扩展的临床前模型,具有转化相关性。
研究设计与样本
- 使用3株DMG患者来源异种移植细胞系,与含神经元、功能性星形胶质细胞和小胶质细胞的人iPSC来源平面神经类器官共培养,并用NanoString GeoMx空间转录组系统进行空间分析。
主要发现
- 3株细胞系均与人类平面神经类器官相互作用并整合,在复杂共培养中显示良好生长条件。
- 空间分辨感兴趣区域分析显示肿瘤细胞分别与小胶质细胞和星形胶质细胞相互作用,混合细胞区域的正常细胞和肿瘤细胞基因特征均存在差异。
- 类器官中DMG细胞在转录组和蛋白组水平与DMG患者活检高度相关。
- 多细胞类器官支持传统肿瘤细胞单培养无法实现的药物靶点旁观者毒性筛选。
临床怎么用
- 该模型可作为成本有效且可靠的工具,用于DMG生物学研究和物种匹配的体外药物测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse Midline Glioma H3K27-altered (DMG) is an extremely aggressive and lethal childhood brain cancer that grows within the midline structure of the brain. Current treatment options are only palliative, making DMG in desperate need for therapeutic breakthroughs. One of the major challenges limiting the study of DMG is the lack of reliable preclinical models. In-vivo mouse models are expensive and technically challenging and in-vitro cell culture models lack the essential components of tumor microenvironment (TME) needed to recapitulate the complex biology of these tumors. Scalable human planar neural organoids (PNOs) with multi-cellular make-up can serve as a cost effective and reliable model system to capture DMG biology and allow effective species matched drug testing in-vitro. METHODS: Using 3 separate DMG patient derived xenograft (PDX) cell lines, we spatially profiled a novel scalable human iPSC-derived PNO system containing neurons, functional astrocytes and microglia using the NanoString GeoMx spatial transcriptomics system. RESULTS: We found that all three cell lines interact with and integrate into the human PNOs, demonstrating favorable growth conditions in a complex co-culture. Across spatially resolved regions of interest (ROI’s) tumor cells individually interact with microglia and astrocytes and transcriptomic profiling of these mixed cell ROI’s shows differences in the genetic signatures of both the normal cells (microglia/astrocytes) and the tumor cells. When compared to biopsies obtained directly from DMG patients, DMG cells within PNOs correlate strongly at both transcriptomic and proteomic levels. The multi-cellular PNOs also enabled drug target bystander toxicity screening not possible in a traditional tumor cell only monoculture. CONCLUSION: This study provides a proof-of-concept for scalable PNO modeling for DMG and underscores the translational relevance of this model system.
引用
- Shireman JM, Xie E, Lebakken CS, et al. Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors. J Neurooncol. 2026. PMID: 42098359. doi:10.1007/s11060-026-05515-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。